Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa-Lyonnet

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Scientific Reports|November 12, 2017
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoproteinL L Mariani, S Rivaud-Péchoux, P Charles, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2S R Lakhani, B A Gusterson, J Jacquemier, et al.
American Journal of Human Genetics|June 19, 1998
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international studyS L Neuhausen, A K Godwin, R Gershoni-Baruch, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Science (New York, N.Y.)|October 18, 2003
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Scientific Reports|November 12, 2017
Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoproteinL L Mariani, S Rivaud-Péchoux, P Charles, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2S R Lakhani, B A Gusterson, J Jacquemier, et al.
American Journal of Human Genetics|June 19, 1998
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international studyS L Neuhausen, A K Godwin, R Gershoni-Baruch, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.
British Journal of Cancer|June 26, 2008
Rapid progression of prostate cancer in men with a BRCA2 mutationS A Narod, S Neuhausen, G Vichodez, et al.
Science (New York, N.Y.)|October 18, 2003
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1S Hacein-Bey-Abina, C Von Kalle, M Schmidt, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
Pageof 13